➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Express Scripts
Johnson and Johnson
Colorcon
Baxter

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

THORAZINE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Which patents cover Thorazine, and what generic alternatives are available?

Thorazine is a drug marketed by Glaxosmithkline and is included in two NDAs.

The generic ingredient in THORAZINE is chlorpromazine. There are twenty-four drug master file entries for this compound. Additional details are available on the chlorpromazine profile page.

Summary for THORAZINE
Drug patent expirations by year for THORAZINE
Recent Clinical Trials for THORAZINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Regina Elena Cancer InstitutePhase 2
Carlo Besta Neurological InstitutePhase 2
Marco G Paggi, MD, PhDPhase 2

See all THORAZINE clinical trials

US Patents and Regulatory Information for THORAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline THORAZINE chlorpromazine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 011120-016 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline THORAZINE chlorpromazine hydrochloride CONCENTRATE;ORAL 009149-043 Approved Prior to Jan 1, 1982 DISCN Yes No   Start Trial   Start Trial   Start Trial
Glaxosmithkline THORAZINE chlorpromazine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 011120-019 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Express Scripts
Johnson and Johnson
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.